A protein called MCT2 helps brain cells maintain the protective coating around nerve fibers, and when this protein doesn’t work properly, the coating breaks down and nerves become damaged. According to Gram Research analysis of this 2026 study, a ketogenic diet reversed nerve damage in mice lacking MCT2, suggesting that alternative energy sources might protect brain cells when MCT2 function is impaired—a finding potentially relevant to progressive multiple sclerosis.
Scientists discovered that a special protein called MCT2 helps brain cells maintain the protective coating around nerve fibers, similar to insulation on electrical wires. When this protein doesn’t work properly, the coating breaks down and nerves get damaged—a problem seen in multiple sclerosis. According to Gram Research analysis, a special high-fat diet called the ketogenic diet may help compensate for this problem. This discovery could lead to new treatments that protect the brain by providing alternative fuel sources to brain cells, potentially slowing nerve damage in diseases like MS.
Key Statistics
A 2026 research article published in Nature Communications found that removing MCT2 protein from brain cells caused myelin breakdown, increased inflammation, and axonal damage in mouse spinal cords, effects that were reversed by a ketogenic diet.
MCT2 protein is downregulated in progressive multiple sclerosis patients, according to a 2026 study examining how oligodendrocytes maintain the protective coating around nerve fibers.
Mice lacking MCT2 in their spinal cord white matter showed increased lactate dehydrogenase A in damaged nerve fibers, indicating axonal stress that was alleviated by ketogenic diet intervention.
The Quick Take
- What they studied: How a protein called MCT2 helps brain cells maintain the protective coating (myelin) around nerve fibers and what happens when this protein stops working
- Who participated: Laboratory mice with MCT2 removed from their spinal cord white matter, compared to control mice without this change
- Key finding: When MCT2 was removed, the protective coating around nerves broke down, inflammation increased, and nerves became damaged—but a ketogenic diet reversed these harmful effects
- What it means for you: This research suggests that special diets or treatments targeting energy metabolism in the brain might help protect nerve coatings in diseases like multiple sclerosis, though human studies are still needed to confirm this
The Research Details
Researchers used genetically modified mice to remove the MCT2 protein specifically from brain cells called oligodendrocytes, which are responsible for making and maintaining myelin—the protective coating around nerve fibers. They compared these mice to control mice that still had MCT2. The scientists then measured what happened to the myelin coating, inflammation levels, and nerve damage. They also tested whether a ketogenic diet (high in fat, low in carbohydrates) could reverse the harmful effects they observed.
This approach allowed researchers to understand MCT2’s specific role without affecting other parts of the body. By using a special virus to deliver genetic changes only to the spinal cord, they could isolate the effects in white matter—the part of the brain made up of nerve fibers covered in myelin.
Understanding how individual proteins control brain cell energy metabolism is crucial because many neurodegenerative diseases involve problems with myelin maintenance. By identifying MCT2’s role, researchers can now investigate whether boosting this protein or providing alternative energy sources might prevent or slow nerve damage in conditions like multiple sclerosis.
This study was published in Nature Communications, a highly respected scientific journal. The research used controlled laboratory conditions with genetically modified mice, allowing researchers to isolate specific effects. However, because this is animal research, results may not directly translate to humans. The study provides strong evidence for MCT2’s role in myelin maintenance but represents an early-stage discovery requiring further investigation.
What the Results Show
When MCT2 was removed from oligodendrocytes, several harmful changes occurred: the cells reduced production of enzymes needed to make lipids (fats that form myelin), inflammation increased in the tissue, and the protective myelin coating failed to maintain itself properly. These changes were not seen in control mice, which only showed mild inflammation.
Most importantly, the nerve fibers themselves showed signs of damage when MCT2 was missing. The damaged nerves showed increased levels of an enzyme called lactate dehydrogenase A, suggesting the nerves were stressed and struggling to function properly.
When researchers fed the MCT2-deficient mice a ketogenic diet—a high-fat, low-carbohydrate diet that changes how the brain uses energy—the nerve damage was reversed. This suggests the brain can use alternative fuel sources to compensate when MCT2 isn’t available.
The research found that MCT2 removal didn’t kill oligodendrocytes directly, meaning the protein’s main job isn’t keeping these cells alive. Instead, MCT2 specifically controls how these cells produce the fats needed for myelin and how they respond to inflammation. The study also revealed that nerves themselves can sense when oligodendrocytes aren’t providing proper support, as shown by the increased lactate dehydrogenase A in damaged axons.
Previous research showed that monocarboxylates (simple molecules that cells use for energy) are important fuel sources, but their specific role in brain cells that make myelin was unknown. This study fills that gap by demonstrating MCT2’s critical function. The finding that MCT2 is reduced in progressive multiple sclerosis patients suggests this mechanism may be relevant to human disease, though this connection needs further study.
This research was conducted in mice, not humans, so results may not directly apply to people with MS. The study examined only the spinal cord white matter, not other brain regions. The ketogenic diet experiment was performed in mice, and it’s unclear whether this diet would have the same protective effects in humans or whether it would be practical as a long-term treatment. Additionally, the study doesn’t explain exactly how MCT2 controls lipid production or why inflammation develops when MCT2 is absent.
The Bottom Line
This research is too early-stage to recommend specific treatments for patients. However, it suggests that future therapies targeting brain cell energy metabolism—possibly including ketogenic diet approaches or drugs that enhance MCT2 function—might help protect nerve coatings in MS. Anyone with MS should discuss any dietary changes with their neurologist before making changes.
This research is most relevant to people with progressive multiple sclerosis and researchers studying neurodegenerative diseases. It may eventually inform treatment strategies for other conditions involving myelin damage. People without neurological disease don’t need to change their diet based on this single animal study.
This is basic research identifying a mechanism, not a clinical treatment. It typically takes 5-10 years or more to develop and test new treatments based on discoveries like this. Human clinical trials would be needed before any new therapy could be recommended.
Frequently Asked Questions
What is MCT2 and why is it important for the brain?
MCT2 is a protein that helps brain cells called oligodendrocytes absorb energy-providing molecules. It’s crucial for maintaining myelin—the protective coating around nerve fibers—and supporting nerve health. When MCT2 doesn’t work properly, this protective coating breaks down.
Can a ketogenic diet help with multiple sclerosis?
This mouse study suggests ketogenic diet may help protect nerves when MCT2 function is impaired, but human clinical trials are needed. People with MS should consult their neurologist before making major dietary changes, as individual responses vary.
How does this research connect to progressive MS?
Researchers found that MCT2 protein levels are reduced in progressive MS patients. This study shows that low MCT2 causes myelin breakdown and nerve damage in mice, suggesting this mechanism may contribute to MS progression in humans.
When will this research lead to new MS treatments?
This is early-stage basic research. Developing and testing new treatments typically takes 5-10 years or longer. Scientists must first conduct human studies to confirm these findings apply to people with MS before new therapies can be recommended.
Does this mean everyone should try a ketogenic diet?
No. This research was conducted in mice with a specific genetic change. Healthy people without neurological disease don’t need to change their diet based on this study. Any dietary changes should be discussed with a healthcare provider.
Want to Apply This Research?
- For users interested in metabolic health and neurological wellness, track weekly dietary composition (percentage of carbohydrates, fats, and proteins) and any changes in cognitive clarity or energy levels to establish personal baselines
- Users could experiment with tracking macronutrient ratios during different eating patterns and note any subjective changes in mental clarity, energy, or focus—creating a personal data log that might reveal individual responses to dietary changes
- Establish a 4-week baseline of normal eating patterns, then track any intentional dietary modifications alongside subjective wellness metrics, creating a personal nutrition-cognition journal for discussion with healthcare providers
This research describes early-stage laboratory findings in mice and should not be interpreted as medical advice or a treatment recommendation for multiple sclerosis or any other condition. The study has not been tested in humans. Anyone with multiple sclerosis or other neurological conditions should consult with their neurologist before making dietary changes or considering any new treatments. This article is for educational purposes only and does not replace professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.